Was Treatment the Trigger? Mycosis Fungoides - 19/11/13
Doi : 10.1016/j.amjmed.2013.08.007
Joshua R. Peck, MD a, b, ⁎ 
, Michael P. Frank, MD c, Lawrence R. Peck, DO d
, Michael P. Frank, MD c, Lawrence R. Peck, DO d a Department of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio
b Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio
c Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, Pa
d St. Mary Medical Center, Langhorne, Pa
∗Requests for reprints should be addressed to Joshua R. Peck, MD, Clinical Instructor, House Staff, Wexner Medical Center at the Ohio State University, Department of Internal Medicine, 395 West 12th Avenue, Columbus, OH 43210.
Uma Paniker, MD, Section Editor
Le texte complet de cet article est disponible en PDF.Plan
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the data, a role in writing the manuscript, and met the criteria for authorship including acceptance of responsibility for the scientific content of the manuscript. |
© 2013
Elsevier Inc. Tous droits réservés.
Vol 126 - N° 12
P. 1048-1049 - décembre 2013 Retour au numéro
Article précédent
- A B-wildering Case of Paraplegia: Cobalamin Deficiency
- Roberto A. Leon-Ferre, Benjamin Koch, Lori J. Rosenstein
- Food for Thought: Atrioventricular Dissociation
- Gagan D. Singh, Garret B. Wong, Jeffrey A. Southard, Ezra A. Amsterdam
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?